PT TOMORROW: NL East—Espinosa making the case for larger role

Washington Nationals

If there has been a silver lining to the injury suffered by Anthony Rendon (2B/3B, WAS), it has been the surprising play from Danny Espinosa (2B/SS/3B, WAS). He has done a fine job whenever called upon this season.

It’s a small sample size of 102 AB, but Espinosa has shined. He has been able to boost his ct% to a career high of 75% (12% higher than 2014) while maintaining his power (149 PX). The 28-year-old has also drawn walks at a higher rate than ever before (2015: 12% bb%; career 7% bb%). These gains have resulted into a rather robust .275/.373/.490 slash line with 5 HR. His xBA, xPX and HctX support his current surface stats. After struggling against right-handed pitching for his entire career (.656 OPS vs....

Almost!

You’re just a few clicks away from accessing this feature and hundreds more throughout the year that have a singular goal in mind: Winning your league. Subscribe to BaseballHQ.com here!

Already a subscriber? Sign in here

More From PT Tomorrow

Three key Twins hitters have yet to deliver on the promise they offered as prospects, and time may be running out. Plus, a closer look at Shane Smith, Daniel Schneemann, and Jack Flaherty, and the KC bullpen.
Apr 30 2026 3:05am
The Rangers offense is sputtering and a change at 2B could help kick start their offense.
Apr 29 2026 3:06am
Could Griffin Jax be the answer to the Rays' rotation depth issues? Plus, Volpe nearing a return, upheaval in Boston, and more from around the AL East.
Apr 28 2026 3:05am
The Mets are a hot mess, and the fact that they've been unlucky isn't quite enough to overlook how they've been flat-out bad--but it may still present buying opportunities. Plus: SP in PHI; C in WAS; 2B in ATL; RP in MIA; more.
Apr 27 2026 10:28am
We discuss Dalton Rushing's playing time probability moving forward, highlight a San Diego catcher with a real hit tool, and take a closer look at the Giants bullpen.
Apr 25 2026 3:05am

Tools